A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

Russia

Research Site, Aramil

Research Site, Izhevsk

Research Site, Moscow

Research Site, Perm

Research Site, Saint Petersburg

Research Site, Saratov

Research Site, Yaroslavl